RELATION BETWEEN AUTOIMMUNE LIVER-DISEASES AND VIRAL-HEPATITIS - CLINICAL AND SEROLOGICAL CHARACTERISTICS IN 859 PATIENTS

被引:0
|
作者
LOHSE, AW [1 ]
GERKEN, G [1 ]
MOHR, H [1 ]
LOHR, HF [1 ]
TREICHEL, U [1 ]
DIENES, HP [1 ]
ZUMBUSCHENFELDE, KHM [1 ]
机构
[1] UNIV MAINZ, INST PATHOL, D-55101 MAINZ, GERMANY
来源
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 1995年 / 33卷 / 09期
关键词
AUTOIMMUNE HEPATITIS; VIRAL HEPATITIS; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; AUTOANTIBODIES; LKM; SLA; ANA;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
An etiopathological link between hepatitis virus infection and autoimmune liver disease, in particular autoimmune hepatitis has been suggested. In some patients features of both viral and autoimmune disease are present. We have studied 352 patients with autoimmune liver disease and 507 patients with viral hepa titis for diagnostic characteristics as well as for evidence of an etiological connection. 38 of the 201 patients with hepatitis C (19%) and 42 of the 306 patients with hepatitis B (14%) had significant titres of autoantibodies (ANA, SMA or LKM). SLA autoantibodies were found exclusively in patients with autoimmune liver disease. LKM autoantibody was found in only one of the 201 HCV patients. Evidence of past or present hepatitis B virus and past hepatitis A virus infection was most common in the hepatitis C virus patients and least common in autoimmune hepatitis. 28 of the 352 patients with autoimmune liver diseases tested positive in the second generation anti-HCV ELISA, but only five patients (two with autoimmune hepatitis, one with primary sclerosing cholangitis and two with primary biliary cirrhosis) were positive in confirmatory anti-HCV assays, and only in these could HCV-RNA be isolated. Autoimmune hepatitis patients had significantly higher transaminase, GLDH and IgG levels. HLA-B8, HLA-DR3 and HLA-DR4 were significantly more common in autoimmune hepatitis. Distinction between autoimmune liver disease and viral hepatitis C could be made reliably on clinical and laboratory grounds. Our data show that a link between hepatitis A, B, or C virus infection and autoimmune liver diseases is highly unlikely. Although false positive anti-HCV ELISA results can be found in about 5% of patients with autoimmune liver diseases, true HCV-infection in particular is a rare event.
引用
收藏
页码:527 / 533
页数:7
相关论文
共 48 条
  • [41] Clinical characteristics and outcomes of COVID-19 in patients with autoimmune hepatitis: A population-based matched cohort study
    Krishnan, Arunkumar
    Patel, Ruhee A.
    Hadi, Yousaf Bashir
    Mukherjee, Diptasree
    Shabih, Sarah
    Thakkar, Shyam
    Singh, Shailendra
    Woreta, Tinsay A.
    Alqahtani, Saleh A.
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (01) : 68 - 78
  • [42] High level of persistent liver injury is one of clinical characteristics in treatment-naive acute onset autoimmune hepatitis: experience in a community hospital
    Fujiwara, Keiichi
    Fukuda, Yoshihiro
    Seza, Katsushi
    Saito, Masaya
    Yasui, Shin
    Nakano, Masayuki
    Yokosuka, Osamu
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2016, 23 (03) : 174 - 180
  • [43] Difference in clinical presentation, immunology profile and treatment response of type 1 autoimmune hepatitis between United Kingdom and Singapore patients
    Nwe Ni Than
    Doreen Koay Siew Ching
    James Hodson
    Patrick McDowell
    Jake Mann
    Ravi Gupta
    Ennaliza Salazar
    Jing Hieng Ngu
    Ye Htun Oo
    Hepatology International, 2016, 10 : 673 - 679
  • [44] Difference in clinical presentation, immunology profile and treatment response of type 1 autoimmune hepatitis between United Kingdom and Singapore patients
    Nwe Ni Than
    Doreen Koay Siew Ching
    Hodson, James
    McDowell, Patrick
    Mann, Jake
    Gupta, Ravi
    Salazar, Ennaliza
    Jing Hieng Ngu
    Ye Htun Oo
    HEPATOLOGY INTERNATIONAL, 2016, 10 (04) : 673 - 679
  • [45] Anti-CYP2D6 antibodies detected by quantitative radioligand assay and relation to antibodies to liver-specific arginase in patients with autoimmune hepatitis
    Kimura, M
    Tatsumi, K
    Tada, H
    Izumi, Y
    Kaneko, A
    Kato, M
    Masuzawa, M
    Ikemoto, M
    Yabusaki, Y
    Hidaka, Y
    Amino, N
    CLINICA CHIMICA ACTA, 2002, 316 (1-2) : 155 - 164
  • [46] Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury
    Lleo, Ana
    Cazzagon, Nora
    Rigamonti, Cristina
    Cabibbo, Giuseppe
    Lai, Quirino
    Muratori, Luigi
    Carbone, Marco
    DIGESTIVE AND LIVER DISEASE, 2022, 54 (06) : 722 - 726
  • [47] CD4+Foxp3+CD25+/- Tregs characterize liver tissue specimens of patients suffering from drug-induced autoimmune hepatitis: A clinical-pathological study
    Qu, Li-Mei
    Wang, Shu-Hua
    Yang, Kun
    Brigstock, David R.
    Sun, Li
    Gao, Run-Ping
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2018, 17 (02) : 133 - 139
  • [48] CD4~+Foxp3~+CD25+/-Tregs characterize liver tissue specimens of patients suffering from drug-induced autoimmune hepatitis: A clinical-pathological study
    Li-Mei Qu
    Shu-Hua Wang
    Kun Yang
    David R.Brigstock
    Li Sun
    Run-Ping Gao
    Hepatobiliary & Pancreatic Diseases International, 2018, 17 (02) : 133 - 139